Next Article in Journal
Optimizing Traffic Flow: Utilizing IR and Load Cell Sensors for Cost-Effective Traffic Congestion Alleviation at Smart City Intersections
Previous Article in Journal
Rheological and Microstructural Characteristics of Commercial Mayonnaise-Type Emulsions: A Chemometric Analysis
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Proceeding Paper

In Vivo Biocompatibility and Biodegradability of Bilayer Films Based on Hyaluronic Acid and Chitosan for Ear, Nose and Throat Surgery †

1
ENT Department, Pavlov First Saint Petersburg State Medical University, 197022 St. Petersburg, Russia
2
Institute BioEngineering, ITMO University, 197101 St. Petersburg, Russia
3
Saint-Petersburg State Research Institute of Phthisiopulmonology of the Ministry of Healthcare of the Russian Federation, 191036 St. Petersburg, Russia
4
Laboratory of Hearing and Speech, Pavlov First Saint Petersburg State Medical University, 197022 St. Petersburg, Russia
5
Experimental Pathomorphology Research Group, Almazov National Medical Research Center of the Ministry of Health of the Russian Federation, 197341 St. Petersburg, Russia
*
Author to whom correspondence should be addressed.
Presented at the 4th International Electronic Conference on Applied Sciences, 27 October–10 November 2023; Available online: https://asec2023.sciforum.net/.
Eng. Proc. 2023, 56(1), 32; https://doi.org/10.3390/ASEC2023-15260
Published: 26 October 2023
(This article belongs to the Proceedings of The 4th International Electronic Conference on Applied Sciences)

Abstract

:
Septal cartilage defects and tympanic membrane perforations are some of the main challenging clinical problems in modern ENT (Ear, Nose and Throat) surgery. Polymer films based on biocompatible and biodegradable polymers seem to represent prospective materials for surgical reconstruction of such defects. In this study, we present the results of pilot in vivo experiments of the biocompatibility and biodegradability of bilayer films obtained via the casting method from hyaluronic acid (MW = 1300 kDa) and chitosan (500 and 900 kDa) polymer solutions. The total toxicity, pro-inflammatory activity, biodegradation rate and proliferative potential of the connective tissue of the dermis in the implantation area were evaluated on days 7, 14, 30 and 50 after the implantation. The studied samples demonstrated negligible overall acute and chronic toxicity. The influence of the preparation technique as well as the effect of chitosan’s MW on the biodegradation rate are also demonstrated. These bilayer polymer films can be recommended for ENT surgery, in particular for the reconstruction of the nasal septum and tympanic membrane.

1. Introduction

One of the most topical problems belonging to ENT (Ear, Nose and Throat) surgery is related to the successful reconstruction of various defects (e.g., perforations) occurring under the influence of different factors. Thus, nasal septal perforations are a common defect which is diagnosed in 0.9–2.1% of the global population [1]. Septal perforations may be caused by various factors: uncontrolled administration of nasal drops and sprays for breathing recovery containing alpha-adrenomimetics (naphazoline, xylometazoline, oxymetazoline, etc.), intranasal synthetic steroids (mometasone, budesonide, beclomethasone, fluticasone, etc.) [2,3,4], other topical drugs (e.g., desmopressin against diabetes insipidus [5]), prolonged recovery period after septoplasty (e.g., for crooked nasal septum treatment) [6] and serious trauma with massive cartilage destruction [7]. Under these pathological conditions, the vessels become dilapidated and sclerotic, and the mucous membrane together with the cartilage tissue atrophies and is also thin and eroded [8].
Defects of the tympanic membrane usually result from longtime and untreated inflammatory processes (e.g., chronic otopyosis) and traumas, especially baric and acoustic ones [9,10].
The above-mentioned injuries cannot be reconstructed even with advanced ENT microsurgery because of the lack of biocompatible composite materials for ENT prosthetic devices. Such materials have to be applied for a significant area of the missing/damaged body part and have to promote a volumetric repair process of functional restoration of the cartilage, mucosa and connective tissue matrix for ENT organs and their parts [11,12]. Moreover, apart from the exploitation properties, such materials should have antibacterial effects or be easy sterilized without the changing of properties, because of the formation of bacterial or/and fungal biofilms on the material surface [13].
Film materials based on biocompatible and biodegradable polymers seem to be suitable materials for ENT surgery due to their unique properties. For example, chitosan, being a natural polysaccharide obtained from chitin, has its own antibacterial activity against Gram-negative and Gram-positive bacteria [14]. Hyaluronic acid, another member of the polysaccharide family, has a unique set of properties and is recommended for biocompatible and biodegradable devices, such as reconstructive materials for ENT surgery [15]. Moreover, natural antibacterial agents could be loaded into hyaluronic acid matrixes to obtain materials with excellent antimicrobial efficacy with synergy of action [16].
The aim of this study is to evaluate the in vivo biocompatibility and biodegradability of bilayer cast films based on high-molecular-weight (MW) hyaluronic acid and chitosan with various MWs for potential use as modern materials for surgical reconstruction of the tympanic membrane and septal cartilage defects. The combination of chitosan and hyaluronic acid leads to the formation of a polyelectrolyte complex [17] on the interface region between the two polymer layers, which results in the possibility of biodegradable rate regulation and the combination of polymer properties.
In this study, the total toxicity, pro-inflammatory activity, biodegradation rate and proliferative potential of the connective tissue of the dermis in the implantation area were analyzed on days 7, 14, 30 and 50 after the surgical implantation of the samples using 20 Wistar rats (weight 220–240 g). The studied polymer samples demonstrated negligible overall acute and chronic toxicity. Moreover, the influence of the preparation technique as well as the effect of chitosan MW on the biodegradation rate are demonstrated. These bilayer polymer films can be recommended for the reconstruction of the nasal septum and tympanic membrane.

2. Materials and Methods

2.1. Materials

Hyaluronic acid sodium salt HA-T from Streptococcus equi with molecular weight (MW) equal to 1300 kDa was obtained from Bloomage Freda Biopharm Corporation Limited (Jinan, China). Chitosan with MWs equal to 500 kDa and 900 kDa was purchased from LLC BioProgress (Moscow Region, Russian Federation). Glacial acetic acid (99.5% ACS, MW = 60.052 g/mol) was obtained from JSC EKOS-1 (Moscow, Russian Federation). Distilled water was prepared using laboratory distiller apparatus. All materials were used without additional purification.

2.2. Polymer Solution Preparation

Individual polymer solutions were prepared as follows:
-
Hyaluronic acid was dissolved in the required volume of distilled water to obtain 2.0 wt. % polymer solution.
-
Chitosan was dissolved in the 1.0% v/v aqueous acetic acid solution to obtain a polymer concentration equal to 2.0 wt. %.
Each solution was prepared overnight using a magnetic stirrer at ambient temperature and relative humidity. After the preparation, the solutions were kept for stabilization and deaeration.

2.3. Film Casting

Polymer bilayer films based on hyaluronic acid and chitosan were prepared via layer-by-layer (LbL) casting of polymer solutions. The detailed methodology and the key properties of films prepared was demonstrated earlier [18]. Briefly, chitosan solution was transferred into sterilized Petri dishes and dried at ambient conditions for 24 h. Hyaluronic acid solution was transferred on the chitosan film and dried for 120 h in ambient conditions. After the drying, half of the bilayer polymer films were heated at 100 °C in a chamber drier for 5 min and washed with distilled water for 30 min. Non-heat-treated films were washed with distilled water immediately after the drying. After the washing, the bilayer films were dehumidified at ambient conditions for 24 h.
The scheme of film preparation is demonstrated in Figure 1.

2.4. In Vivo Pilot Experiments

For the in vivo assay, 30 Wistar rats (weight 220–240 g) were used. Total toxicity, pro-inflammatory activity, biodegradation rate and proliferative potential of the connective tissue of the dermis in the implantation area were evaluated on days 7, 14, 30 and 50 after the subcutaneous implantation.
The experimental groups of rats were divided as demonstrated in Table 1.
The film samples were sterilized via UV irradiation for 1 h. An incision of 10 mm in length in the dorsal region along the middle line in the line of sight was introduced in the aseptic system (Zoletil 100) on the operating field. With the help of a raspator, soft tissues were separated with the formation of a bed between the dermis and the sterno-lumbar fascia. Flavored material (Prolene 6.0) was added to the ranunculus.
During the experiment, the weight of the animals; the condition of the postoperative wound; the severity of local edema; the size; the condition and density of the encapsulated implant; and the histological picture of the surrounding tissues were evaluated.
Histological analysis was performed on paraffin sections stained with hematoxylin and eosin, using the Mallory method and toluidine blue. Macrophages were detected using primary monoclonal mouse antibodies Anti-CD68 antibody (ab 31630) (Abcam) and a multimeric biotin-free system (D&A, Reveal-Biotin-Free Polyvalent DAB, Spring Bioscience Corporation, USA). A nonparametric statistical method (Mann–Whitney U test) was used to assess the reliability of the differences between the groups.
The differences between the averages were considered significant at p < 0.05.

3. Results and Discussion

The absence of mortality and the increase in animals’ weight in the experimental groups indicate the absence of acute and subacute toxicity in the studied materials. The absence of suture failure and purulent complications in the postoperative period illustrates its good biocompatibility.
In the acute period after the implantation, tissue edema was observed in all groups, persisting up to 7–8 days after the surgery (Figure 2).
During the experiment, a palpatory examination of the skin of the implantation zone revealed a different intensity of bioresorption in the studied samples. Thus, by day 30, complete resorption of the CT500HA film, obtained without heat treatment, was noted. Samples with 500 and 900 kDa chitosan subjected to the heat treatment continued to be detected throughout the observation period. It is noted that their biodegradation occurs through the swelling stage of the polymer matrix and with the formation of a stable reactive capsule of a foreign body. The CT900HA(t) sample subjected to heat treatment showed the longest duration of stay in the tissues, which indicates the minimum rate of the biodegradation of this material (Figure 3).
For all experimental groups, no visual formation of scar tissue deforming the thickness of the skin and subcutaneous tissue in the implantation zone was detected. Postoperative sutures at the end of the experiment did not differ from the group of sham-operated animals.
Thus, the rate of biodegradation of the studied samples of bilayer polymer films for reconstructive purposes in ENT surgery is the following sequence: CT500HA ≥ CT900HA > CT500HA(t) > CT900HA(t) (Table 2).
Thus, the intensity of bioresorption of hybrid polymer systems depends on the polymer’s MW and the use of heat treatment during the film preparation process.
Histological analysis of skin samples revealed insignificant reactive proliferation of connective tissue and the absence of aseptic inflammation. The biodegradation of films passes through the stage of swelling of the polymer matrix associated with the hydrophilicity of the material and with persistent cellular infiltration mainly by tissue macrophages and migrating monocytes. The involvement of CD68+ cells, mainly in the form of giant multinucleated cells of foreign bodies, in the formation of the surrounding capsule and subsequent bioresorption is shown. The absence of eosinophils and signs of mast cell degranulation indicate the bioinertness of the matrix material (absence of allergenic properties).

4. Conclusions

For the development of a polymer-based implant for surgical reconstruction of tissue defects that requires a long-term stay in the body, the molecular weight of polymers forming a bilayer hybrid film that is not more critical in comparison with the severity of the polyelectrolyte complex being created, are stimulated, in particular, by heat treatment conditions. The chitosan/hyaluronic acid-based bilayer films obtained under these conditions demonstrate the following: the absence of acute toxicity, signs of reactive aseptic inflammation and allergenicity. The biocompatibility of these materials and the low rate of biodegradation, combined with the absence of scar deformation on the surrounding tissues, allow one to consider them as prospective materials for reconstructive ENT surgery.

Author Contributions

Conceptualization, P.S., S.M. and S.Z.; methodology, M.N., P.S., T.G. and S.Z.; validation, M.N. and S.Z.; formal analysis, M.N.; investigation, M.N., P.S., T.G. and S.Z.; resources, P.S., S.M. and S.Z.; writing—original draft preparation, M.N., P.S., S.M. and S.Z.; writing—review and editing, S.M. and S.Z.; visualization, M.N., P.S. and S.Z.; supervision, A.B., S.M. and S.Z.; project administration, S.M. and S.Z. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

All procedures were performed in accordance with the Guide for the Care and Use of Laboratory Animals (NIH publication No. 85–23, revised 1996) and the European Convention for the Protection of Vertebrate Animals used for Experimental and other Scientific Purposes. The Institutional Animal Care and Use Committee at Almazov National Medical Research Centre approved the study protocol (Protocol Number PZ_21-02#Zhuravskii S.G. V3. March 09, 2021). All efforts were made to protect the animals and minimize their suffering during the study. The experiments complied with the ARRIVE guidelines https://arriveguidelines.org/ (accessed on 15 October 2023).

Informed Consent Statement

Not applicable.

Data Availability Statement

The data presented in this study are available on request from the corresponding author.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Rosenthal, J.C.; Wisotzky, E.L.; Matuschek, C.; Hobl, M.; Hilsmann, A.; Eisert, P.; Uecker, F.C. Endoscopic measurement of nasal septum perforations. Endoskopische Vermessung von Nasenscheidewandperforationen. HNO 2022, 70 (Suppl. 1), 1–7. [Google Scholar] [CrossRef] [PubMed]
  2. Cervin, A.; Andersson, M. Intranasal steroids and septum perforation—An overlooked complication? A description of the course of events and a discussion of the causes. Rhinology 1998, 36, 128–132. [Google Scholar]
  3. Waddell, A.N.; Patel, S.K.; Toma, A.G.; Maw, A.R. Intranasal steroid sprays in the treatment of rhinitis: Is one better than another? J. Laryngol. Otol. 2003, 117, 843–845. [Google Scholar] [CrossRef] [PubMed]
  4. Boynuegri, S.; Cayonu, M.; Tuna, E.U.; Kurukahvecioglu, S.; Ozcan, K.M.; Turkay, B.; Cingi, C. The Effect of Nasal Septal Perforation and its Treatment on Objective Sleep and Breathing Parameters. Med. Sci. Monit. 2016, 22, 501–507. [Google Scholar] [CrossRef] [PubMed]
  5. Brake, D.A.; Hamilton, G.S.; Bansberg, S.F. Nasal Septal Perforation Due to Desmopressin Nasal Spray Use. Ear Nose Throat J. 2021, 2021, 1–4. [Google Scholar] [CrossRef] [PubMed]
  6. Dąbrowska-Bień, J.; Skarżyński, P.H.; Gwizdalska, I.; Łazęcka, K.; Skarżyński, H. Complications in septoplasty based on a large group of 5639 patients. Eur. Arch. Otorhinolaryngol. 2018, 275, 1789–1794. [Google Scholar] [CrossRef] [PubMed]
  7. Taylor, R.J.; Sherris, D.A. Prosthetics for nasal perforations: A systematic review and meta-analysis. Otolaryngol. Head Neck Surg. 2015, 152, 803–810. [Google Scholar] [CrossRef] [PubMed]
  8. Pereira, C.; Alfonso Santamaría, A.; Langdon, C.; López-Chacón, M.; Hernández-Rodríguez, J.; Alobid, I. Nasoseptal Perforation: From Etiology to Treatment. Curr. Allergy Asthma Rep. 2018, 18, 5. [Google Scholar] [CrossRef] [PubMed]
  9. Castelhano, L.; Correia, F.; Colaço, T.; Reis, L.; Escada, P. Tympanic membrane perforations: The importance of etiology, size and location. Eur. Arch. Otorhinolaryngol. 2022, 279, 4325–4333. [Google Scholar] [CrossRef] [PubMed]
  10. Rasool, S.; Ahmad, F.; Ahmad, R. Traumatic tympanic membrane perforations: An overview in tertiary care hospital. Egypt J. Otolaryngol. 2016, 32, 187–190. [Google Scholar] [CrossRef]
  11. Niermeyer, W.L.; Rodman, C.; Li, M.M.; Chiang, T. Tissue engineering applications in otolaryngology. Laryngoscope Investig. Otolaryngol. 2020, 5, 630–648. [Google Scholar] [CrossRef] [PubMed]
  12. Heilingoetter, A.; Smith, S.; Malhotra, P.; Johnson, J.; Chiang, T. Applications of Electrospinning for Tissue Engineering in Otolaryngology. Ann. Otol. Rhinol. Laryngol. 2021, 130, 395–404. [Google Scholar] [CrossRef] [PubMed]
  13. Spałek, J.; Ociepa, P.; Deptuła, P.; Piktel, E.; Daniluk, T.; Król, G.; Góźdź, S.; Bucki, R.; Okła, S. Biocompatible Materials in Otorhinolaryngology and Their Antibacterial Properties. Int. J. Mol. Sci. 2022, 23, 2575. [Google Scholar] [CrossRef] [PubMed]
  14. Yilmaz Atay, H. Antibacterial Activity of Chitosan-Based Systems. In Functional Chitosan: Drug Delivery and Biomedical Applications, 1st ed.; Jana, S., Jana, S., Eds.; Nature Singapore Pte Ltd.: Singapore, 2019; pp. 457–489. [Google Scholar] [CrossRef]
  15. Abi Zeid Daou, C.; Bassim, M. Hyaluronic acid in otology: Its uses, advantages and drawbacks—A review. Am. J. Otolaryngol. 2020, 41, 102375. [Google Scholar] [CrossRef] [PubMed]
  16. Snetkov, P.; Rogacheva, E.; Kremleva, A.; Morozkina, S.; Uspenskaya, M.; Kraeva, L. In-Vitro Antibacterial Activity of Curcumin-Loaded Nanofibers Based on Hyaluronic Acid against Multidrug-Resistant ESKAPE Pathogens. Pharmaceutics 2022, 14, 1186. [Google Scholar] [CrossRef] [PubMed]
  17. Barroso, N.; Guaresti, O.; Pérez-Álvarez, L.; Ruiz-Rubio, L.; Gabilondo, N.; Vilas-Vilela, J.L. Self-healable hyaluronic acid/chitosan polyelectrolyte complex hydrogels and multilayers. Eur. Polym. J. 2019, 120, 109268. [Google Scholar] [CrossRef]
  18. Gribinichenko, T.N.; Uspenskaya, M.V.; Snetkov, P.P.; Olekhnovich, R.O. Bi-Layered Films based on Sodium Hyaluronate and Chitosan as Materials for ENT Surgery. In Proceedings of the 2022 IEEE-EMBS Conference on Biomedical Engineering and Sciences (IECBES), Kuala Lumpur, Malaysia, 7–9 December 2022; pp. 338–343. [Google Scholar] [CrossRef]
Figure 1. The scheme of bilayer film preparation: (1) chitosan solution casting, (2) chitosan film drying (24 h), (3) hyaluronic acid solution casting, (4) the drying of bilayer film at ambient conditions (120 h), (5) heat treatment (100 °C × 5 min), (6) washing with distilled water.
Figure 1. The scheme of bilayer film preparation: (1) chitosan solution casting, (2) chitosan film drying (24 h), (3) hyaluronic acid solution casting, (4) the drying of bilayer film at ambient conditions (120 h), (5) heat treatment (100 °C × 5 min), (6) washing with distilled water.
Engproc 56 00032 g001
Figure 2. A photo of an animal with the implantation of a polymer film on the 3rd day of the postoperative period.
Figure 2. A photo of an animal with the implantation of a polymer film on the 3rd day of the postoperative period.
Engproc 56 00032 g002
Figure 3. Implantation zone (a) and the type of product during necropsy (b) by the 50th day of observation. Sample CT900HA(t). Macropreparations.
Figure 3. Implantation zone (a) and the type of product during necropsy (b) by the 50th day of observation. Sample CT900HA(t). Macropreparations.
Engproc 56 00032 g003
Table 1. Experimental groups of rats.
Table 1. Experimental groups of rats.
Group NumberPolymers, Their MWs and Sample Preparation
Methodology
Sample Name
Intact Group 1--
Control Group 2
(False operated)
--
Group 3Chitosan (900 kDa) + Hyaluronic acid (1300 kDa)
LbL polymer casting + heat treatment 100 °C × 5 min
CT900HA(t)
Group 4Chitosan (500 kDa) + Hyaluronic acid (1300 kDa)
LbL polymer casting + heat treatment 100 °C × 5 min
CT500HA(t)
Group 5Chitosan (900 kDa) + Hyaluronic acid (1300 kDa)
LbL polymer casting without heat treatment
CT900HA
Group 6Chitosan (500 kDa) + Hyaluronic acid (1300 kDa)
LbL polymer casting without heat treatment
CT500HA
Table 2. Diameter of polymer implants during necropsy by day 50 after implantation (M ± m).
Table 2. Diameter of polymer implants during necropsy by day 50 after implantation (M ± m).
Group NumberSample NameImplant Diameter, mmMann–Whitney U Test
3 (n = 5)CT500HA0.8 ± 0.45
4 (n = 5)CT900HA1.2 ± 0.84U3–4 = 8.5
5 (n = 5)CT500HA(t)5.0 ± 1.22U4–5 = 0
6 (n = 5)CT900HA(t)9.0 ± 1.00U5–6 = 0
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Naumenko, M.; Snetkov, P.; Gribinichenko, T.; Bervinova, A.; Morozkina, S.; Zhuravskii, S. In Vivo Biocompatibility and Biodegradability of Bilayer Films Based on Hyaluronic Acid and Chitosan for Ear, Nose and Throat Surgery. Eng. Proc. 2023, 56, 32. https://doi.org/10.3390/ASEC2023-15260

AMA Style

Naumenko M, Snetkov P, Gribinichenko T, Bervinova A, Morozkina S, Zhuravskii S. In Vivo Biocompatibility and Biodegradability of Bilayer Films Based on Hyaluronic Acid and Chitosan for Ear, Nose and Throat Surgery. Engineering Proceedings. 2023; 56(1):32. https://doi.org/10.3390/ASEC2023-15260

Chicago/Turabian Style

Naumenko, Maria, Petr Snetkov, Tatiana Gribinichenko, Anna Bervinova, Svetlana Morozkina, and Sergei Zhuravskii. 2023. "In Vivo Biocompatibility and Biodegradability of Bilayer Films Based on Hyaluronic Acid and Chitosan for Ear, Nose and Throat Surgery" Engineering Proceedings 56, no. 1: 32. https://doi.org/10.3390/ASEC2023-15260

Article Metrics

Back to TopTop